Ovarian cancer: progress and continuing controversies in management.
about
Molecular profiling of platinum resistant ovarian cancer.Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroidsA terrible beauty: a physician's story of ovarian cancer.Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft modelsLoss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress.Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell ProliferationWhole abdominal radiotherapy in ovarian cancer.Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors.EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1.Microarray-based gene expression studies in ovarian cancer.Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling.miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer.EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo.Internet-Based Group Intervention for Ovarian Cancer Survivors: Feasibility and Preliminary Results.AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance.Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa Cells.
P2860
Q33227163-166E8E4A-7B72-410F-AE1B-EDDAC3C443C7Q33321330-12E808BD-1E68-4652-9E00-FC0D33159898Q35941981-72787F19-91C1-4FCD-9DD0-B6C310C3E71DQ35953034-BE310A9F-9B38-4552-89C2-79A6C94786C6Q36642559-F8678837-3982-42F6-8386-3849353F5740Q36688597-9FB3F333-94A4-441D-88E8-C57481E841C7Q37204678-66731E73-8BE5-4461-BB43-9112157415D2Q37272407-78F50C9D-C2A2-474E-BF23-34A0D230C8C2Q37392270-9C3288C2-D4A0-48B8-98E2-5EC02F36EA45Q37624379-86EE13C9-C9D8-447E-9E2A-5CC75C271775Q37683036-8B470E75-122E-47B4-A45C-A8AB667B6EB4Q37832928-DA402914-93CD-42A5-AF67-73363344FC68Q38917585-9488B18C-E179-401E-B09B-89F2797AF349Q38952951-3B63F9AA-0EF8-4390-80C9-5BFF657C4E7EQ39612445-C9CBE6F3-08AE-44B2-B6B5-82A7CA4A97F0Q47559279-9B239183-A3DB-4DED-82B7-3A184671E2E6Q47971254-C16FB577-5115-4C14-90FB-5C14F74E9A6DQ49233935-BCEC1321-B41D-4FE4-B073-57686E86FF05
P2860
Ovarian cancer: progress and continuing controversies in management.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Ovarian cancer: progress and continuing controversies in management.
@ast
Ovarian cancer: progress and continuing controversies in management.
@en
Ovarian cancer: progress and continuing controversies in management.
@nl
type
label
Ovarian cancer: progress and continuing controversies in management.
@ast
Ovarian cancer: progress and continuing controversies in management.
@en
Ovarian cancer: progress and continuing controversies in management.
@nl
prefLabel
Ovarian cancer: progress and continuing controversies in management.
@ast
Ovarian cancer: progress and continuing controversies in management.
@en
Ovarian cancer: progress and continuing controversies in management.
@nl
P1476
Ovarian cancer: progress and continuing controversies in management.
@en
P2093
Charlotte Moss
Stan B Kaye
P304
P356
10.1016/S0959-8049(02)00161-2
P577
2002-09-01T00:00:00Z